Pandemics and Alertness member WG1 (Understanding the virus) and WG2 (Fighting the virus), LINXS Fellow

MD, PhD, Resident Physician and Researcher, Sahlgrenska University Hospital and the University of Gothenburg, Gothenburg, Sweden

Inga Rimkuté has been a Clinical Resident in Clinical Immunology and Transfusion Medicine at Sahlgrenska University Hospital and the leader of the Human Norovirus Research Group at the University of Gothenburg since 2025. She received her M.D. from Vilnius University, Lithuania, in 2015 and earned her Ph.D. in Medical Science from the University of Gothenburg in 2019. Her doctoral research focused on glycobiology, immunology, and vaccinology in the field of human norovirus. Following her Ph.D., she completed a postdoctoral fellowship at the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), USA. During this time, she developed the first non-human primate model of human norovirus infection, isolated broadly neutralizing human monoclonal antibodies against norovirus, and gained expertise in high-dimensional flow cytometry as well as human and non-human primate intestinal organoid culture systems. Her research focuses on human norovirus biology, host-pathogen interactions, antiviral immune responses, and the development of next-generation vaccines and antibody-based therapies against human noroviruses.